arrow left
arrow right
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
						
                                

Preview

FILED: NEW YORK COUNTY CLERK 05/06/2022 07:32 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 698 RECEIVED NYSCEF: 05/06/2022 SUPREME COURT OF THE STATE OF NEW YORK COUNTY OF NEW YORK ----------------------------------------------------------- X CRESCO LABS NEW YORK, LLC, a New : York limited liability company, and CRESCO : LABS, LLC, an Illinois limited liability : Index No. 652343/2018 company, : : Hon. Andrew Borrok : Plaintiffs/Counterclaim Defendants, : Mot. Seq. No. 11 : v. : ORAL ARGUMENT REQUESTED : : FIORELLO PHARMACEUTICALS, INC., a : New York corporation, : : Defendant/Counterclaimant. ----------------------------------------------------------- X PLAINTIFFS’ MEMORANDUM OF LAW IN OPPOSITION TO DEFENDANT’S MOTION FOR SUMMARY JUDGMENT 1 of 31 FILED: NEW YORK COUNTY CLERK 05/06/2022 07:32 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 698 RECEIVED NYSCEF: 05/06/2022 TABLE OF CONTENTS PRELIMINARY STATEMENT .................................................................................................... 1 STATEMENT OF FACTS ............................................................................................................. 3 A. Cresco’s Plan to Acquire a NY-Licensed Company Before Going Public ...................... 3 B. Cresco and Fiorello Entered into the LOI ........................................................................ 4 C. The No-Shop Provision .................................................................................................... 4 D. Fiorello Immediately and Repeatedly Breached the No-Shop Provision ........................ 5 1. Liberty .......................................................................................................................... 5 2. Sea Hunter .................................................................................................................... 6 3. GTI................................................................................................................................ 6 4. Sirota and Yoss’s Implausible Denials ......................................................................... 7 E. After Obtaining Higher Offers, Fiorello Stalled the Deal with Cresco ............................ 7 F. Fiorello’s New Deal Closed ............................................................................................. 8 G. Cresco Entered into a Replacement Transaction.............................................................. 8 I. Expert Discovery ................................................................................................................. 9 J. Fiorello’s Refusal to Participate in Discovery Following Cresco’s Opposition ................ 10 ARGUMENT ................................................................................................................................ 11 I. Fiorello Breached the No-Shop Provision ......................................................................... 11 II. Fiorello’s Breach Caused Damages to Cresco ............................................................... 12 A. It Is Premature and Inefficient to Limit Cresco’s Damages Now .............................. 12 B. Replacement Cost Damages ....................................................................................... 12 C. Disgorgement Damages .............................................................................................. 15 D. DOH Would Have Approved the Deal ....................................................................... 16 E. The Requirement of Shareholder Approval Does Not Prevent Cresco From Proving Damages ................................................................................................................................ 18 F. Cresco Is Not Limited As a Matter of Law to Reliance Damages ............................. 19 CONCLUSION ............................................................................................................................. 23 2 of 31 FILED: NEW YORK COUNTY CLERK 05/06/2022 07:32 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 698 RECEIVED NYSCEF: 05/06/2022 TABLE OF AUTHORITIES Page(s) Cases In re 131 Liquidating Corp., 44 F. Supp. 2d 552 (S.D.N.Y. 1999)........................................................................................21 180 Water St. Assocs., L.P. v. Lehman Bros. Holdings, 7 A.D.3d 316 (1st Dep’t 2004) ................................................................................................23 Ashland Mgmt. Inc. v. Janien, 82 N.Y.2d 395 (1993) ..............................................................................................................13 Bi-Econ Mkt. v. Harleysville Ins. Co., 10 N.Y.3d 187 (2008) ..............................................................................................................17 Carco Group, Inc. v. Maconachy, 718 F.3d 72 (2d Cir. 2013).......................................................................................................16 Cerberus Capital Mgmt., L.P. v. Snelling & Snelling, Inc., No. 60045/2005, 12 Misc. 3d 1187(A), (Sup. Ct. N.Y. Cnty. 2005) .....................13, 14, 18, 21 Dorchester Publishing Co. v. Lanier, 2006 WL 4388035 (S.D.N.Y. Mar. 19, 2006) .........................................................................15 Fairbrook Leasing, Inc. v. Mesaba Aviation, Inc., 519 F.3d 421 (8th Cir. 2008) ...................................................................................................22 Ficus Investments, Inc. v. Private Capital Mgmt., LLC, 61 A.D.3d 1 (1st Dep’t 2009) ..................................................................................................13 Frank Felix Assocs., Ltd. v. Austin Drugs, Inc., 111 F.3d 284 (2d Cir. 1997).....................................................................................................12 Freund v. Washington Square Press, 34 N.Y.2d 379 (1974) ..............................................................................................................13 Genuine Parts Co. v. Essendant Inc., 2019 WL 4257160 (Del. Ch. Sept. 9, 2019) ............................................................................11 Gomez v. Bicknell, 302 A.D.2d 107 (2d Dep’t 2002) .............................................................................................16 Goodstein. Columbia Park Golf Course, Inc. v. City of Kennewick, 248 P.3d 1067 (Wash. App. 2011)...........................................................................................22 iii 3 of 31 FILED: NEW YORK COUNTY CLERK 05/06/2022 07:32 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 698 RECEIVED NYSCEF: 05/06/2022 Goodstein Const. Corp. v. City of New York, 145 Misc.2d 870 (Sup. Ct. N.Y. Cnty. 1989) ..........................................................................20 Goodstein Const. Corp. v. City of New York, 80 N.Y.2d 366 (N.Y. 1992) ............................................................................................. passim Jenkins v. T.S.I. Holdings, Inc., 1 P.3d 891 (Kan. 2000) ............................................................................................................13 Kenford Co. v. Erie Cty., 73 N.Y.2d 312 (1989) ........................................................................................................13, 14 In re Kenneth Cole Prods., Inc., 27 N.Y.3d 268 (2016) ..............................................................................................................13 NACCO Indus., Inc. v. Applica Inc., 997 A.2d 1 (Del. Ch. 2009).............................................................................................. passim Network Enterprises, Inc. v. APBA Offshore Productions, Inc., 427 F.Supp.2d 463 (S.D.N.Y. 2006)........................................................................................15 Pesa v. Yoma Dev. Grp. Inc, 18 N.Y.3d 527 (2012) ..............................................................................................................23 In re Primedia, Inc. S’holders Litig., 67 A.3d 455 (Del. Ch. 2013)....................................................................................................16 PSC Metals, Inc. v. S. Recycling, LLC, 2018 WL 1566822 (M.D. Tenn. Mar. 29, 2018) .....................................................................11 Raven Capital Mgt. LLC v. Georgia Film Fund 72, LLC, 2021 WL 465980 (Sup. Ct. NY. Cnty. 2021) ..........................................................................23 RSB Bedford Assocs., LLC v. Ricky’s Williamsburg, Inc., 91 A.D.3d 16 (1st Dep’t 2011) ................................................................................................18 Siga Techs., Inc. v. PharmAthene, Inc., 132 A.3d 1108 (Del. 2015) ......................................................................................................14 Umbach v. Carrington Inv. Partners (US), LP, 851 F.3d 147 (2d Cir. 2017).....................................................................................................14 Wathne Imports, Ltd. v. PRL USA, Inc., 101 A.D.3d 83 (1st Dep’t 2012) ..............................................................................................14 Wave-Division Holdings LLC v. Millennium Digital Media Systems, L.L.C., 2010 WL 3706624 (Del. Ch. Sept. 17, 2010) ....................................................................15, 18 iv 4 of 31 FILED: NEW YORK COUNTY CLERK 05/06/2022 07:32 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 698 RECEIVED NYSCEF: 05/06/2022 Westerbeke Corp. v. Daihatsu Motor Co., 304 F.3d 200 (2d Cir. 2002).....................................................................................................21 Worldwide Srvcs., Ltd v. Bombardier Aerospace Corp., 2015 WL 5671724 (S.D.N.Y. Sept. 22, 2015) .........................................................................15 Xiang Fu He v. Troon Mgmt., Inc., 34 N.Y.3d 167 (2019) ..............................................................................................................11 Y.J.D. Rest. Supply Co. v. Dib, 98 Misc. 2d 462 (Sup. Ct. N.Y. Cnty. 1979) ...........................................................................16 Other Authorities Restatement (Third) of Restitution and Unjust Enrichment § 39(1) (2011) ..................................15 v 5 of 31 FILED: NEW YORK COUNTY CLERK 05/06/2022 07:32 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 698 RECEIVED NYSCEF: 05/06/2022 PRELIMINARY STATEMENT Fiorello brazenly breached the No-Shop Provision in an “Equity Purchase Agreement Letter of Intent” (the “LOI”) with Cresco by negotiating acquisition proposals with three buyers during the 30-day exclusivity period in the LOI. Once Fiorello had established that two other buyers were willing to pay more than the base price in the LOI, Fiorello slow-walked negotiation of a definitive agreement with Cresco until it purported to expire. Fiorello ultimately sold itself to one of the operators with which it had engaged in prohibited discussions, for much more than the price in the LOI. In the meantime, Cresco scrupulously abided by its reciprocal obligation not to discuss a potential transaction with any New York company other than Fiorello. Because Cresco’s business plan required it to acquire a New York-licensed operator before Cresco went public on the Canadian Securities Exchange, Cresco then paid three times as much as the price in the LOI to acquire the only available substitute. In moving to dismiss Cresco’s claim, Fiorello relies on testimony from its co-CEOs, Eric Sirota and Susan Yoss, that there was “no discussion of deal terms during the exclusivity period.” Br. 2. The Court should not accept this implausible testimony, let alone on a motion for summary judgment. The contemporaneous emails, text messages, and phone records show that literally the same day Fiorello signed the LOI with Cresco, Sirota spoke with the CEO of a competing multistate operator (“MSO”). That conversation led to an in-person meeting, text messages, phone calls, and two written offers. Also on the same day they signed the LOI, Sirota and Yoss discussed whether they could engage in discussions with a second MSO. That conversation also led to an in-person meeting and an NDA stating that the MSO “and Fiorello Pharmaceuticals Inc. desire to discuss a possible transaction.” Ex. 23, Ex. 25. 1 6 of 31 FILED: NEW YORK COUNTY CLERK 05/06/2022 07:32 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 698 RECEIVED NYSCEF: 05/06/2022 Later in the exclusivity period, Fiorello also engaged in prohibited discussions with the MSO that ultimately purchased it, Green Thumb Industries (“GTI”). Those discussions included an outgoing call from Sirota to GTI’s founder, which resulted in GTI transmitting a draft letter of intent later that same day. In light of this evidence, the Court should not credit Sirota and Yoss’s preposterous story that their many discussions had nothing to do with a possible acquisition. It is also noteworthy that Sirota and Yoss created a phony paper trail suggesting their offers were unsolicited. Fiorello’s motion seeks an alternative ruling that even if it did breach the No-Shop, Cresco is not entitled to damages above its out-of-pocket costs to negotiate and diligence the deal with Fiorello. But numerous courts, in New York and Delaware, have held that damages, including the plaintiff’s replacement costs, are available when defendants willfully breach no- shop provisions—including when the provision is reflected in a letter of intent. Replacement cost damages are particularly appropriate here. When Cresco entered into the LOI with Fiorello, MSOs like Cresco were in a game of musical chairs with New York licensees like Fiorello: Cresco was competing with other MSOs to acquire the few New York licensed companies still available, and Cresco did not want to get shut out or put into a bidding war for the last available licensee. Because the No-Shop Provision required both parties to forgo discussions about alternative New York transactions during the exclusivity period, Fiorello’s breach forced Cresco to pay an extraordinary price for the last available New York licensee. In its motion, Fiorello argues that Cresco is not entitled to damages because Cresco’s deal with Fiorello would not have been approved by the New York State Department of Health (“DOH”). Br. 2. No admissible evidence supports Fiorello’s argument, which is based solely on its own hearsay. In any event, both Cresco and Fiorello were able to get their subsequent 2 7 of 31 FILED: NEW YORK COUNTY CLERK 05/06/2022 07:32 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 698 RECEIVED NYSCEF: 05/06/2022 transactions approved, despite initial rejections, by working cooperatively with the DOH and their counterparties. The jury is entitled to conclude that if Fiorello had not breached, Cresco and Fiorello would have concluded a definitive agreement on terms that are sufficiently definite to form a “stable foundation” for estimating damages. Fiorello also argues that after Goodstein Const. Corp. v. City of New York, 80 N.Y.2d 366 (N.Y. 1992), a party can never recover anything more than out-of-pocket damages for breach of an LOI. But Goodstein does not involve the breach of a No-Shop Provision in which the target sold itself in a similar transaction for a higher price – precisely the risk Cresco contracted to avoid. Rather, in Goodstein, the City had an express unilateral right to terminate the agreement at any time, and it exercised that right to pursue an entirely different development plan than the one in the agreement with the plaintiff. The developers plainly assumed that risk. If Fiorello were right that the only damages available for breach of a no-shop provision in an LOI were out-of-pocket costs, then no target in an M&A transaction would ever abide by one, because the potential gains from a breach would be hundreds or even thousands of times greater than the potential liability. Thus, as the Delaware Chancery Court has stated: Parties bargain for provisions in acquisition agreements because those provisions mean something. Bidders in particular secure rights under acquisition agreements to protect themselves against being used as a stalking horse and as consideration for making target- specific investments of time and resources in particular acquisitions…. It is critical to our law that those bargained-for rights be enforced, [including, …] in the appropriate case, through monetary remedies including awards of damages. NACCO Indus., Inc. v. Applica Inc., 997 A.2d 1, 19–20 (Del. Ch. 2009). STATEMENT OF FACTS A. Cresco’s Plan to Acquire a NY-Licensed Company Before Going Public Cresco is an MSO. In 2018, in anticipation of becoming a publicly traded company, its business model depended on building a national footprint within the state medical cannabis 3 8 of 31 FILED: NEW YORK COUNTY CLERK 05/06/2022 07:32 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 698 RECEIVED NYSCEF: 05/06/2022 markets. New York State was essential to this plan, because it is a large market and had issued a relatively limited number of licenses. Affidavit of Charles Bachtell (“Bachtell_Aff.”) ¶3. But by the time Cresco negotiated with Fiorello in late 2017, only two licensees were still available: Defendant Fiorello (ultimately acquired by GTI) and Valley Agriceuticals (“Valley”) (which Cresco later acquired). Under these circumstances, exclusivity was crucial to ensure Cresco would not get shut out or put in a bidding war. B. Cresco and Fiorello Entered into the LOI On February 14 and 15, 2018, the parties executed the LOI for Cresco to acquire 100% of the outstanding shares of Fiorello. The parties agreed that Cresco would pay at least $22.5 million in total consideration, with the first $10 million due on closing, and $6.25 million due each of the following two years. Ex. A.1 Cresco also agreed to an additional payment of up to $10 million, contingent upon New York legalizing recreational sales of marijuana within four years. Id. at 2. These financial terms remained consistent through Fiorello’s final draft of the definitive agreement. Hipp_Aff. ¶22.i. “Promptly following the execution of this LOI,” the parties were obligated to work in good faith to complete due diligence and execute a definitive agreement consistent with the terms of the LOI. The Parties further agreed that they would “endeavor to execute the Definitive Agreement as soon as practicable,” subject to the necessary approvals. The LOI was “intended to be binding on the Parties until supplanted by a definitive agreement.” Id. C. The No-Shop Provision The LOI includes a mutual No-Shop Provision which provides: 1 References to lettered exhibits, “Br.” and “Sirota_Aff.” refer to the papers submitted by Fiorello in support of its motion. References to numbered exhibits refer to the exhibits submitted by Cresco in opposition. 4 9 of 31 FILED: NEW YORK COUNTY CLERK 05/06/2022 07:32 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 698 RECEIVED NYSCEF: 05/06/2022 By executing this LOI, the Parties agree that they will not discuss or enter into any transaction with any third-party involving (a) the sale of a majority equity stake in, or all or substantially all of the assets of, Fiorello or any subsidiary or parent entities of Fiorello, including without limitation, any sale or other transfer of the grower and dispensary license used or owned by Fiorello to any third-party or (b) the purchase of any equity interest in or assets of another medical marijuana company in the State of New York by Buyer. Id. This provision was effective for thirty business days (through March 30, 2018). Unlike a typical no-shop provision, this No-Shop Provision was mutual, meaning that while Fiorello was prohibited from engaging in discussions with other potential acquirers, Cresco was similarly prohibited from engaging in discussions with other potential targets. During negotiations, Fiorello revised the draft LOI to clarify and expand subsection (b) to restrict Cresco. Bachtell_Aff. ¶9; Ex. 64. As a result, entering into the LOI subjected Cresco to more than just the expense of conducting diligence into Fiorello; Cresco also incurred the risk that while it tried to conclude a definitive agreement with Fiorello, the market price would go up or the last remaining NY- licensed company would become unavailable. D. Fiorello Immediately and Repeatedly Breached the No-Shop Provision 1. Liberty The same day Sirota executed the LOI, he scheduled a conference call with Yoss and George Scorsis, CEO of Liberty Health Sciences (“Liberty”), a cannabis company in Florida that was interested in expanding to New York. Affirmation of Jason P. Hipp in Opposition to Defendant’s Motion for Summary Judgment (“Hipp_Aff.”) ¶15.a; Ex. 16. The call lasted 25 minutes. Ex. 14. A week later, Sirota and Yoss met in person with Scorsis and Liberty’s CFO. Ex. 17. 5 10 of 31 FILED: NEW YORK COUNTY CLERK 05/06/2022 07:32 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 698 RECEIVED NYSCEF: 05/06/2022 On March 2, Scorsis texted Sirota, “We are sending you an unsolicited in [the] next 24 hours.” Ex. AA. Twelve minutes later, Sirota called Scorsis, and they spoke for eight minutes. Ex. 14. Within 24 hours, Scorsis sent Fiorello a proposed letter of intent with a purchase price of $27.5 million—precisely $5 million more than the price in the LOI. Ex. BB. After receiving this offer, Yoss and Sirota decided to pursue it. On March 3, Yoss texted Sirota: “The offer is much better..thinking about how we can consider it...” Ex. 18. Then, on March 9, Sirota called Scorsis and spoke for four minutes. Ex. 14. Sirota called Scorsis again on March 12. That call lasted seven minutes. Id. On March 14, Scorsis texted Sirota: “Hey Eric, I am still thinking about this. Can I call you in 1 hr.” Ex. AA. Scorsis and Sirota had three more calls that evening. On March 15, Scorsis emailed his CFO with instructions about how to email Fiorello and “make it appear as if we have not had discussions.” Ex. 19. The next morning, the CFO sent a revised proposed letter of intent to Sirota and Yoss. Ex. DD. The revised letter of intent had similar price terms to the initial offer, but removed the exclusivity provision, presumably at Fiorello’s request. Hipp_Aff. ¶15.k. 2. Sea Hunter Two days after executing the LOI, Fiorello requested an in-person meeting with the CEO of Sea Hunter Holdings, a cannabis company with operations in four states. Id. ¶16.b. Fiorello then executed an NDA stating that the parties “desire to discuss a possible transaction.” Id. ¶16.d. 3. GTI On March 14, 2018, GTI’s founder Ben Kovler contacted Sirota and Yoss via email, requesting a “chat.” Ex. 28. Three days later, Kovler emailed them again. Id. Fiorello knew 6 11 of 31 FILED: NEW YORK COUNTY CLERK 05/06/2022 07:32 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 698 RECEIVED NYSCEF: 05/06/2022 that GTI, with which it had discussed a potential transaction months earlier (Ex. 26), wanted a “chance” to bid before Fiorello completed a sale. Ex. 27. On March 20, Sirota placed a telephone call to Kovler, with Yoss also on the line. Ex. 15; Hipp_Aff. ¶18.d. A few minutes later, Kovler called Sirota, and they continued to talk for another four minutes, while Yoss remained on the line. Id. After those telephone calls, Kovler instructed GTI’s lawyers to draft an offer to acquire Fiorello. Ex. 9 at 109. Later that day, Kovler sent a proposed letter of intent to Fiorello with total consideration of $25 million. Ex. EE. Kovler’s cover email submitting GTI’s offer stated that “we haven’t spoken in a while,” even though they had spoken that day. Id. Sirota’s conversations with Kovler led to a flurry of communications among Fiorello board members, shareholders, and attorneys on March 20 – even before receipt of GTI’s proposed letter of intent – showing that Fiorello expected to receive an offer as a result of those conversations. Hipp_Aff. ¶¶18.f-18.g. 4. Sirota and Yoss’s Implausible Denials The predicate for Fiorello’s motion is Sirota and Yoss’s testimony that they did not discuss a transaction with GTI, Liberty, or Sea Hunter during the exclusivity period. Br. 16. But for nearly every phone call or email during the exclusivity period, Sirota and Yoss conveniently could not remember or explain what had been discussed. Hipp_Aff. ¶¶15.l, 19 (summarizing implausible testimony). E. After Obtaining Higher Offers, Fiorello Stalled the Deal with Cresco After breaching the No-Shop Provision and obtaining higher offers, Fiorello stopped working in good faith to consummate a transaction with Cresco, and instead ran out the clock until exclusivity ended. For example, Fiorello provided no written feedback on the draft 7 12 of 31 FILED: NEW YORK COUNTY CLERK 05/06/2022 07:32 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 698 RECEIVED NYSCEF: 05/06/2022 definitive agreement until days before the end of the exclusivity period, and had not completed responding to Cresco’s initial due diligence requests. Fiorello’s stalling is described in more detail in the Hipp Affirmation ¶¶21-24. F. Fiorello’s New Deal Closed Fiorello purported to terminate the LOI at the end of the exclusivity period. Fiorello ultimately entered into an agreement to sell its stock to GTI for $42.6 million in cash and 1.7 million shares of GTI. Hipp_Aff. ¶29. According to Fiorello, DOH originally refused to approve the deal because Fiorello was not operational and the transaction included a contingent cash payment dependent on New York legalizing cannabis for recreational purposes. Fiorello and GTI were able to surmount both these obstacles. Sirota_Aff. ¶53. In lieu of a contingent cash payment, GTI agreed to give Fiorello’s shareholders substantial equity in GTI—allowing them to share in the upside from legalization. Ex. 48. G. Cresco Entered into a Replacement Transaction Cresco abided by the No-Shop Provision and pursued a replacement transaction only after it became clear that it could not acquire Fiorello. Bachtell_Aff. ¶11. Cresco ultimately purchased Valley on October 24, 2018. DOH initially rejected the deal, but as with GTI and Fiorello, after Cresco supported Valley’s efforts to become operational, DOH approved it. Id. ¶¶16-20. DOH approved the deal even though it included contingent consideration pursuant to which shareholders would be entitled to Cresco shares worth approximately $23.7 million if New York legalized recreational sales of cannabis. Ex. 71 § 3.2; Bachtell_Aff. ¶23; Ex. 1 at 324:22- 325:6. DOH was notified that the deal included contingent consideration. Hipp_Aff. ¶36; Ex. 73. 8 13 of 31 FILED: NEW YORK COUNTY CLERK 05/06/2022 07:32 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 698 RECEIVED NYSCEF: 05/06/2022 Cresco’s acquisition closed in October 2019. Cresco acquired Valley for total consideration of up to $129.6 million (including cash, equity, warrants, and deferred consideration), about three times as much as the cost to acquire Fiorello. Ex. 53 at 43; Ex. 55 at CRES00011114. This amount dwarfs the maximum total payment in the LOI ($32.5 million). At the time, Valley was—like Fiorello—a barely operational company whose value derived primarily from its possession of a New York license. There were no meaningful distinctions between Fiorello and Valley. Bachtell_Aff. ¶15. H. The Motion to Dismiss Cresco filed an Amended Complaint, which included claims for breach of the No-Shop Provision and for breach of the commitment for Fiorello to sell itself to Cresco. Ex. C. On May 24, 2019, this Court sustained the claim for breach of the No-Shop Provision, holding that the Amended Complaint adequately alleged “the existence of a valid and binding agreement” with respect to the No-Shop Provision, which Fiorello breached. Ex. B at 7. By contrast, the Court dismissed Cresco’s claim for breach of the sale obligation because it was “an agreement to agree.” Id. at 9. I. Expert Discovery At a court conference, Fiorello proposed to delay expert discovery until after Fiorello had moved for summary judgment and the Court had ruled on that motion. The Court declined to delay expert discovery. After this ruling, Cresco repeatedly attempted to negotiate an expert discovery schedule with Fiorello, but Fiorello refused. Hipp_Aff. ¶39. Instead, Fiorello filed the instant motion, with no schedule for expert discovery in place, and without knowing Cresco’s damages theories or expert evidence, i.e., Fiorello attempted to force the schedule the Court had rejected. 9 14 of 31 FILED: NEW YORK COUNTY CLERK 05/06/2022 07:32 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 698 RECEIVED NYSCEF: 05/06/2022 Mr. Davidson, a valuations expert with M&A experience including in the cannabis industry, prepared a report assessing Cresco’s damages. He opined that a binding exclusivity provision is an important element of a preliminary agreement, but “two-way” exclusivity is rare and demonstrates that Cresco incurred an additional cost from entering into the LOI – the cost of waiting to speak to other potential targets. Ex. 72. Mr. Davidson concluded that Cresco lost as much as $85 million as a result of Fiorello’s breach. That loss calculation is based on the difference between the amount Cresco was forced to pay for a replacement transaction and the amount it could have paid for Fiorello. Mr. Davidson also calculated disgorgement damages. After the parties had fully briefed summary judgment motions, the Court set a deadline for expert discovery. Hipp_Aff. ¶40. During their depositions, both of Fiorello’s experts testified that a mutual No-Shop Provision is rare, and that they have frequently seen parties to a deal overcome obstacles to regulatory and shareholder approval. Id. ¶¶41-42. J. Fiorello’s Refusal to Participate in Discovery Following Cresco’s Opposition After Cresco served its summary judgment opposition, the Court authorized Fiorello to take limited additional discovery on the issue of DOH’s willingness to approve a deal that included consideration contingent on adult legalization. Id. ¶43. Cresco served discovery requests limited to that issue. Id. ¶44. Fiorello refused to respond to Cresco’s requests. Id. As a result, Fiorello has failed to produce admissible evidence to support its contention that DOH would not have approved a transaction that included consideration contingent upon adult legalization. Fiorello also refused to respond to contention interrogatories. Id. ¶46. 10 15 of 31 FILED: NEW YORK COUNTY CLERK 05/06/2022 07:32 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 698 RECEIVED NYSCEF: 05/06/2022 ARGUMENT I. Fiorello Breached the No-Shop Provision The No-Shop Provision prohibited Fiorello from “discuss[ing] . . . any transaction” to sell Fiorello. Courts have interpreted similar provisions broadly. For example, one court observed that “[t]he point of the exclusivity provision is to prevent [the seller] from engaging in any discussion—no matter how informal or cursory—that might influence [the seller’s] participation in its negotiations with [the plaintiff],” and cause the seller “to drag their feet while waiting out expiration of the exclusivity provision.” PSC Metals, Inc. v. S. Recycling, LLC, 2018 WL 1566822, at *5 (M.D. Tenn. Mar. 29, 2018). See also NACCO, 997 A.2d at 14-16 (an “outgoing call” informing a third party that it “would likely succeed with an all-cash offer” breached no- shop clause which prohibited “any discussions” of a “Competing Transaction” and thus “was not limited to soliciting a competing bid”); Genuine Parts Co. v. Essendant Inc., 2019 WL 4257160, at *10-11 (Del. Ch. Sept. 9, 2019) (allegations that defendant “conveyed to [a third party] that a revised offer would be accepted,” “thereby encouraging it to resubmit its offer with a slight alteration,” were sufficient to establish breach). Here, there is voluminous evidence of “discussions of any transaction”: in-person meetings, calls, and text messages with three potential acquirers, culminating in written offers from two of them. Supra at 5-8. This is evidence of an extraordinarily willful and persistent breach. Fiorello cannot rest on Sirota and Yoss’s disingenuous denials, which require “credibility determinations that are not a proper basis for summary judgment.” Xiang Fu He v. Troon Mgmt., Inc., 34 N.Y.3d 167, 175 (2019). Nor can Fiorello benefit from the fact that most of the prohibited discussions were oral, rather than in writing. Br. 16. The fact that sophisticated parties bound to an exclusivity 11 16 of 31 FILED: NEW YORK COUNTY CLERK 05/06/2022 07:32 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 698 RECEIVED NYSCEF: 05/06/2022 provision did not memorialize breaching discussions does not mean that no discussions occurred. The emails, text messages, and phone records together are enough for a factfinder to conclude that there were, in fact, significant discussions. They also show that Sirota and Yoss strategically relied on oral communications and instructed their counterparties to do the same. Hipp_Aff. ¶¶12-18. Fiorello’s motion on the merits is frivolous.2 II. Fiorello’s Breach Caused Damages to Cresco Fiorello contends that Cresco’s damages should be limited “to its reasonable out-of- pocket expenses associated with its performance of the LOI,” because “Cresco cannot establish that Fiorello’s alleged breach caused its alleged injuries,” and seeks to exclude “replacement costs and lost profits.” Br. 18, 24. These arguments have no merit. A. It Is Premature and Inefficient to Limit Cresco’s Damages Now To begin, it is premature to limit damages now, where Fiorello’s arguments are highly fact dependent, and disputed factual issues remain. Further, because Fiorello moved for summary judgment prior to expert discovery, Fiorello’s motion is limited to only one of the damages theories Cresco actually intends to pursue at trial. The Court should consider damages only after the case is litigated on the merits.